HCP - HCP, Inc.
| Previous Close | 28.91 |
| Open | 28.97 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 800 |
| Day's Range | 28.96 - 29.27 |
| 52 Week Range | 21.48 - 30.27 |
| Volume | 3,749,409 |
| Avg. Volume | 3,524,862 |
| Market Cap | 13.82B |
| Beta (3Y Monthly) | 0.52 |
| PE Ratio (TTM) | 80.56 |
| EPS (TTM) | 0.36 |
| Earnings Date | Feb 11, 2019 - Feb 15, 2019 |
| Forward Dividend & Yield | 1.48 (5.12%) |
| Ex-Dividend Date | 2018-11-02 |
| 1y Target Est | 28.78 |
- Zacks•3 days ago
HCP Prices Upsized Public Offering of 15M Common Shares
HCP increases public offering of common stock to 15 million shares, and enters into a forward sale agreement for 13 million shares as well.
- PR Newswire•3 days ago
HCP Upsizes and Prices Public Offering of 15,000,000 Shares of Common Stock
IRVINE, Calif., Dec. 10, 2018 /PRNewswire/ -- HCP, Inc. (HCP) (the "Company") announced today that it has agreed to sell 15,000,000 shares of its common stock, consisting of 2,000,000 shares offered directly by the Company and 13,000,000 shares offered on a forward basis in connection with the forward sale agreement described below, at a price of $28.90 per share (before deducting underwriting discounts and commissions). The 15,000,000 share offering represents a 1,000,000 share upsize to the originally proposed 14,000,000 share offering. The forward purchaser (as described below) has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of the Company's common stock. BofA Merrill Lynch is acting as lead book-runner and Citigroup, RBC Capital Markets and UBS Investment Bank are acting as additional book-runners for this offering.
- PR Newswire•3 days ago
HCP Announces Public Offering of Common Stock
IRVINE, Calif., Dec. 10, 2018 /PRNewswire/ -- HCP, Inc. (HCP) (the "Company") announced today that it has commenced a public offering of an aggregate of 14,000,000 shares of its common stock, consisting of 2,000,000 shares offered directly by the Company and 12,000,000 shares offered on a forward basis in connection with the forward sale agreement described below. The forward purchaser (as described below) expects to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of the Company's common stock. BofA Merrill Lynch is acting as book-runner for this offering.
- Zacks•14 days ago
HCP (HCP) Up 2.4% Since Last Earnings Report: Can It Continue?
HCP (HCP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Motley Fool•14 days ago
Is It Time to Buy These Beaten-Up Bargains in Healthcare?
The stock market's November swoon has put these top healthcare stocks on sale.
- Motley Fool•14 days ago
Is This Healthcare REIT Best for Dividends?
A restructuring is positioning HCP for a recovery.
- Simply Wall St.•20 days ago
How To Look At HCP Inc (NYSE:HCP)
HCP Inc is a US$14b large-cap, real estate investment trust (REIT) based in Irvine, United States. REITs are basically a portfolio of income-producing real estate investments, which are owned and Read More...
GuruFocus.com•24 days agoStocks Barrow, Hanley, Mewhinney & Strauss Keeps Buying
Barrow, Hanley, Mewhinney & Strauss, which serves as a subadvisor to more than 45 equity and fixed-income mutual funds, bought shares of the following stocks in both the second and third quarters. Warren Buffett (Trades, Portfolio) is the largest shareholder of the company among the gurus with 6.55% of outstanding shares, followed by Dodge & Cox 4.64%, First Eagle Investment (Trades, Portfolio) with 1.93% and Chris Davis (Trades, Portfolio) with 1.77%. The company's largest guru shareholder is First Pacific Advisors (Trades, Portfolio) with 0.49% of outstanding shares, followed by Spiros Segalas (Trades, Portfolio) with 0.46%, Steven Romick (Trades, Portfolio) with 0.38% and Barrow, Hanley, Mewhinney & Strauss with 0.32%.
- Zacks•28 days ago
HPT vs. HCP: Which Stock Should Value Investors Buy Now?
HPT vs. HCP: Which Stock Is the Better Value Option?
- American City Business Journals•last month
Eyeing faster path for sickle cell drug, Peninsula biotech plots expansion — for a higher price
One of the first tenants in The Cove at Oyster Point is taking the last building in the South San Francisco development as rents in the region hit new highs.
- GlobeNewswire•last month
Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP — Future Expectations, Projections Moving into 2018
NEW YORK, Nov. 06, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Thomson Reuters StreetEvents•last month
Edited Transcript of HCP earnings conference call or presentation 31-Oct-18 4:00pm GMT
Q3 2018 HCP Inc Earnings Call
- Motley Fool•last month
How Safe Are HCP and Its Dividend?
This REIT has a massive 5.4% yield, but is it sustainable?
Motley Fool•last monthHCP Inc (HCP) Q3 2018 Earnings Conference Call Transcript
HCP earnings call for the period ending September 30, 2018.
- PR Newswire•last month
HCP Upgraded by S&P Global Ratings to BBB+ with Stable Outlook
IRVINE, Calif. , Oct. 31, 2018 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that S&P Global Ratings ("S&P") upgraded its corporate credit rating to BBB+ from BBB, with a stable outlook. ...
- Zacks•last month
HCP (HCP) Surpasses Q3 FFO Estimates
HCP (HCP) delivered FFO and revenue surprises of 2.33% and -0.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Zacks•last month
HCP Tops Q3 FFO Estimates on NOI Growth, Misses on Revenues
HCP's third-quarter performance indicates year-over-year growth in three-month cash SPP net operating income (NOI) for the company's total portfolio.
- Associated Press•last month
HCP: 3Q Earnings Snapshot
The Irvine, California-based real estate investment trust said it had funds from operations of $208.2 million, or 44 cents per share, in the period. The average estimate of 11 analysts surveyed by Zacks ...
- PR Newswire•last month
HCP Reports Third Quarter 2018 Results
IRVINE, Calif. , Oct. 31, 2018 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced results for the third quarter ended September 30, 2018. For the quarter, we generated net income of $0.21 per share, ...
- Zacks•last month
REITs Queued for Q3 Earnings on Oct 31: FRT, MAC & More
Let's delve into the factors that will likely impact Q3 results of Federal Realty (FRT), Macerich (MAC), Realty Income (O), Mid America Apartment (MAA) and HCP.
- Zacks•2 months ago
Can Demographic Tailwinds Drive HCP's Earnings This Season?
Amid growth in asking rents, HCP will likely report higher net operating income for its senior housing portfolio in the third quarter. However, higher interest cost may suppress the bottom line.
- PR Newswire•2 months ago
HCP Declares Quarterly Cash Dividend on Common Stock
IRVINE, Calif. , Oct. 25, 2018 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share. The dividend will be paid ...
